NCT06113315
Enrolling By Invitation
Not Applicable
An Observational Study of Sarcoma Patients Treated With Immunotherapy at Memorial Sloan Kettering Cancer Center
ConditionsSarcoma
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Sarcoma
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Enrollment
- 250
- Locations
- 7
- Primary Endpoint
- prospectively collect and store blood
- Status
- Enrolling By Invitation
- Last Updated
- 6 months ago
Overview
Brief Summary
The researchers are doing this study to improve their knowledge about immunotherapy use and how effective it is as a treatment for people with sarcoma by collecting information from participants' medical records who have been treated with immune checkpoint blockade or T-cell receptor-based therapy.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Participants must have a histologic diagnosis of sarcoma confirmed by an MSK pathologist.
- •Any prospectively identified patient being treated or to be treated with an immune checkpoint inhibitor, such as anti-PD-1, anti-PD-L1, anti-CTLA-4, or anti-LAG3 inhibitor, either as monotherapy or in combination with additional systemic therapy OR any prospectively identified patient being treated or to be treated with ACT-based treatment including but not limited to lifileucil, Afamitresgene autoleucel, and letetresgene autoleuce o Novel immune checkpoints inhibitors that are developed after submission of this protocol will also be included) Please Note: there is no age requirement. Patients of all ages are eligible to enroll
Exclusion Criteria
- •Patient unwilling to consent to collection of historical and longitudinal clinicopathologic data in the patient medical record from baseline (the period prior to ICB or ACT initiation), during, and after ICB or ACT treatment
Outcomes
Primary Outcomes
prospectively collect and store blood
Time Frame: up to 5 years
of sarcoma patients treated with ICB or ACT
Study Sites (7)
Loading locations...
Similar Trials
Terminated
Not Applicable
Surveillance of Patients With Adenocarcinoma of the Gastroesophageal Junction or EsophagusAdenocarcinoma EsophagusNCT02991547The Guthrie Clinic3
Recruiting
Not Applicable
Ion Therapy Patient RegistryIon Beam Radiation Therapy for Tumor PatientsNCT03049072EBG MedAustron GmbH2,800
Terminated
Not Applicable
Data Collection of Demographics and Perioperative Care of Patients Undergoing Laparoscopic SurgeryLaparoscopyNCT00490126M.D. Anderson Cancer Center31
Active, not recruiting
Not Applicable
PRO-VISION: Patient Reported Outcomes-Based Monitoring of VEGF-Inhibitor Side Effects in ONcologyRenal Cell CarcinomaNCT05592665UNC Lineberger Comprehensive Cancer Center42
Terminated
Not Applicable
Long-Term Follow-up Study of Patients Who Received PB127 Ultrasound Imaging AgentCoronary Artery DiseaseNCT00584714Point Biomedical300